2,985 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 933 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.71B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 933 | Existing positions reduced: 1,460

Holders
2,985
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.28B
Puts
$3.87B
Net Calls
Net Calls Change

Top Sellers

1 -$644M
2 -$337M
3 -$293M
4
JP Morgan Chase
JP Morgan Chase
New York
-$285M
5
Barclays
Barclays
United Kingdom
-$277M
Name Holding Trade Value Shares
Change
Change in
Stake
2451
$259K
2452
$258K
2453
$258K
2454
$258K
2455
$258K
2456
$258K
2457
$258K
2458
$257K
2459
$257K
2460
$257K
2461
$256K
2462
$255K
2463
$255K
2464
$255K
2465
$254K
2466
$253K
2467
$253K
2468
$252K
2469
$252K
2470
$252K
2471
$252K
2472
$251K
2473
$250K
2474
$250K
2475
$250K